Patent details

EP1382336 Title: USE OF THE ABC EXPRESSION PROMOTOR PIOGLITAZONE FOR THE TREATMENT OF ARTERIOSCLEROSIS OBLITERANS

Basic Information

Publication number:
EP1382336
PCT Application Number:
PCT/JP/2002/004072
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027205848
PCT Publication Number:
WO/2002/087580
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
USE OF THE ABC EXPRESSION PROMOTOR PIOGLITAZONE FOR THE TREATMENT OF ARTERIOSCLEROSIS OBLITERANS
French Title of Invention:
UTILISATION DU PROMOTEUR D'EXPRESSION D'ABC PIOGLITAZONE POUR LE TRAITEMENT DE L'ARTERIOSCLEROSE OBLITERANS
German Title of Invention:
VERWENDUNG DES ABC-EXPRESSIONSPROMOTORS PIOGLITAZON ZUR BEHANDLUNG VON ARTERIOSKLEROSE OBLITERANS
SPC Number:

Dates

Filing date:
24/04/2002
Grant date:
08/09/2010
EP Publication Date:
08/09/2010
PCT Publication Date:
07/11/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/01/2004
EP B1 Publication Date:
08/09/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/04/2011
Expiration date:
24/04/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/04/2002
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka, Japan (JP)

Inventor

1

Name:
HIRAKATA Masao
Address:
Japan (JP)

2

Name:
FUSE Hiromitsu
Address:
Japan (JP)

3

Name:
TOZAWA Ryuichi
Address:
Japan (JP)

4

Name:
SUGIYAMA Yasuo
Address:
Japan (JP)

Priority

Priority Number:
2001128222
Priority Date:
25/04/2001
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 31/4439;
Filing date Document type Number of pages